M. Thompson

发表

Barriers and facilitators to influenza vaccination and vaccine coverage in a cohort of health care personnel.

E. Kennedy, A. Naleway, E. Henkle, 2014, American journal of infection control.

Factors associated with a successful expansion of influenza vaccination among pregnant women in Nicaragua.

J. Bresee, M. Thompson, A. Ropero, 2016, Vaccine.

What do pregnant women think about influenza disease and vaccination practices in selected countries

F. Dawood, Yeny O Tinoco, P. Das, 2021, Human vaccines & immunotherapeutics.

The Pregnancy and Influenza Project: design of an observational case-cohort study to evaluate influenza burden and vaccine effectiveness among pregnant women and their infants.

Jennifer L. Williams, S. Chu, D. Shay, 2011, American journal of obstetrics and gynecology.

Frequency of Acute Respiratory Illnesses and Circulation of Respiratory Viruses in Households With Children Over 3 Surveillance Seasons

A. Monto, J. Petrie, S. Ohmit, 2014, The Journal of infectious diseases.

An international cohort study of birth outcomes associated with hospitalized acute respiratory infection during pregnancy.

Jennifer L. Williams, B. Feldman, M. Katz, 2020, The Journal of infection.

Incidence of influenza during pregnancy and association with pregnancy and perinatal outcomes in three middle-income countries: a multisite prospective longitudinal cohort study.

Howard H. Chang, F. Dawood, S. Lindstrom, 2020, The Lancet. Infectious diseases.

The Association Between Influenza Vaccination and Other Preventative Health Behaviors in a Cohort of Pregnant Women

Jennifer L. Williams, A. Naleway, Sarah Ball, 2015, Health education & behavior : the official publication of the Society for Public Health Education.

Factors associated with recruitment, surveillance participation, and retention in an observational study of pregnant women and influenza

A. Naleway, S. Bozeman, M. Thompson, 2019, BMC Pregnancy and Childbirth.

Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016.

F. Dawood, B. Feldman, M. Katz, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influenza vaccine effectiveness against hospitalizations in children and older adults—Data from South America, 2013–2017. A test negative design

E. Azziz-Baumgartner, M. Thompson, R. Palekar, 2019, Vaccine: X.

Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013☆

E. Azziz-Baumgartner, M. Thompson, R. Palekar, 2017, Vaccine.

Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine

A. Monto, B. Flannery, E. Belongia, 2016, Pediatrics.

Sensitivity and specificity of surveillance case definitions in detection of influenza and respiratory syncytial virus among hospitalized patients, New Zealand, 2012-2016.

Q. S. Huang, C. Grant, E. Azziz-Baumgartner, 2021, The Journal of infection.

Comparative Immunogenicity of Enhanced Seasonal Influenza Vaccines in Older Adults: A Systematic Review and Meta-analysis

B. Cowling, Tiffany W. Y. Ng, Huizhi Gao, 2018, Journal of Infectious Diseases.

Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults

E. Belongia, Yuwei Zhu, P. Cheng, 2015, BMC Infectious Diseases.

Cohort profile: the China Ageing REespiratory infections Study (CARES), a prospective cohort study in older adults in Eastern China

Huachen Zhu, B. Cowling, Hongjie Yu, 2017, BMJ Open.

Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza

Fenglin Liu, B. Flannery, T. Tumpey, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development.

Jennifer L. Williams, A. Naleway, Sarah Ball, 2020, Vaccine.

Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season.

A. Monto, B. Flannery, M. Nowalk, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized Open-Label Trial

F. Dawood, W. Cao, B. Flannery, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibody Response to Influenza A(H1N1)pdm09 Among Healthcare Personnel Receiving Trivalent Inactivated Vaccine: Effect of Prior Monovalent Inactivated Vaccine

K. Hancock, A. Naleway, E. Henkle, 2013, The Journal of infectious diseases.

Performance of symptom-based case definitions to identify influenza virus infection among pregnant women in middle-income countries: findings from the Pregnancy and Influenza Multinational Epidemiologic (PRIME) Study.

F. Dawood, Yeny O Tinoco, P. Das, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Pregnancy and Influenza Multinational Epidemiologic (PRIME) study: a prospective cohort study of the impact of influenza during pregnancy among women in middle-income countries

F. Dawood, Yeny O Tinoco, E. Azziz-Baumgartner, 2018, Reproductive Health.

Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic — China, October 2016–February 2017

C. Davis, L. Gubareva, T. Uyeki, 2017, MMWR. Morbidity and mortality weekly report.

Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11.

J. Katz, A. Naleway, Sarah Ball, 2016, Vaccine.

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, MMWR. Morbidity and mortality weekly report.

Underdetection of laboratory-confirmed influenza-associated hospital admissions among infants: a multicentre, prospective study.

M. Lucero, L. Gresh, A. Gordon, 2019, The Lancet. Child & adolescent health.

Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.

A. Levêque, M. Thompson, A. Moren, 2017, The Journal of infection.

Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults.

B. Cowling, V. Fang, Ranawaka A.P.M Perera, 2020, The Journal of infectious diseases.

Severity of influenza and noninfluenza acute respiratory illness among pregnant women, 2010-2012.

A. Naleway, M. Thompson, Stephanie A. Irving, 2015, American journal of obstetrics and gynecology.

Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies.

Jennifer L. Williams, A. Naleway, Sarah Ball, 2014, Vaccine.

Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021

K. Natarajan, S. Grannis, A. Naleway, 2021, MMWR. Morbidity and mortality weekly report.

Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.

William F. Fadel, S. E. Reese, C. Mcevoy, 2021, MMWR. Morbidity and mortality weekly report.

Interactive effects of age and respiratory virus on severe lower respiratory infection

Q. S. Huang, C. Grant, M. Thompson, 2018, Epidemiology and Infection.

Comparison of Laboratory-Confirmed Influenza and Noninfluenza Acute Respiratory Illness in Healthcare Personnel during the 2010–2011 Influenza Season

A. Naleway, E. Henkle, Sarah Ball, 2014, Infection Control & Hospital Epidemiology.

Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, MMWR. Morbidity and mortality weekly report.

Comparison of Respiratory Specimen Collection Methods for Detection of Influenza Virus Infection by Reverse Transcription-PCR: a Literature Review

B. Flannery, M. Thompson, A. Fry, 2019, Journal of Clinical Microbiology.

Predictors of Breastfeeding Initiation and Maintenance in an Integrated Healthcare Setting

S. Kurosky, A. Naleway, M. Thompson, 2017, Journal of human lactation : official journal of International Lactation Consultant Association.

Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study

A. Monto, B. Flannery, A. Gordon, 2019, International journal of epidemiology.

Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine.

A. Monto, A. Uzicanin, D. Shay, 2012, The Journal of infectious diseases.

Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study

Lauren E. W. Olsho, Krystal S. Jovel, K. Hegmann, 2022, JMIR research protocols.

COVID-19 Infection, Reinfection, and Vaccine Effectiveness in Arizona Frontline and Essential Workers: Protocol for a Longitudinal Cohort Study

B. Cowling, K. Ellingson, J. Burgess, 2021, JMIR Research Protocols.

Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.

Andrew L. Phillips, Thomas P. Fabrizio, Lauren E. W. Olsho, 2022, JAMA.

Comparison of Serum Hemagglutinin and Neuraminidase Inhibition Antibodies After 2010–2011 Trivalent Inactivated Influenza Vaccination in Healthcare Personnel

Steven F. Baker, J. Treanor, A. Naleway, 2014, Open forum infectious diseases.

Risk of Severe Influenza among Adults with Chronic Medical Conditions.

Q. S. Huang, M. Baker, M. Thompson, 2019, The Journal of infectious diseases.

Respiratory Syncytial Virus Hospitalization During Pregnancy in 4 High-income Countries, 2010–2016

A. Glatman-Freedman, G. Langley, B. Feldman, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparing Influenza Positivity Rates by Real-Time RT-PCR, Elisa and Viral Culture Methods in Côte D'Ivoire, West Africa, in 2009.

M. Thompson, D. Coulibaly, N. T. Nzussouo, 2013, African journal of infectious diseases.

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Lauren E. W. Olsho, A. Fowlkes, K. Ellingson, 2021, The New England journal of medicine.

Factors associated with real‐time RT‐PCR cycle threshold values among medically attended influenza episodes

B. Flannery, C. Rinaldo, E. Belongia, 2016, Journal of medical virology.

Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers

Lauren E. W. Olsho, K. Hegmann, A. Fowlkes, 2022, The New England journal of medicine.

Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021

S. E. Reese, C. Mcevoy, P. Embí, 2022, medRxiv.

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, MMWR. Morbidity and mortality weekly report.

Estimating Vaccine Effectiveness Against Hospitalized Influenza During Pregnancy: Multicountry Protocol for a Retrospective Cohort Study

M. Russell, B. Feldman, M. Katz, 2018, JMIR research protocols.

Protocol Estimating Vaccine Effectiveness Against Hospitalized Influenza During Pregnancy : Multicountry Protocol for a Retrospective Cohort Study

M. Russell, B. Feldman, M. Katz, 2019 .

Estimating Vaccine Effectiveness Against Hospitalized Influenza During Pregnancy: Multicountry Protocol for a Retrospective Cohort Study (Preprint)

M. Russell, B. Feldman, M. Katz, 2018 .

Vulnerable groups within a vulnerable population: awareness of the A(H1N1)pdm09 pandemic and willingness to be vaccinated among pregnant women in Ivory Coast.

M. Thompson, D. Coulibaly, A. K. N’gattia, 2012, The Journal of infectious diseases.

Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.

P. Yang, Quanyi Wang, Shuangsheng Wu, 2014, Vaccine.

Epidemiology and clinical outcomes of hospitalizations for acute respiratory or febrile illness and laboratory-confirmed influenza among pregnant women during six influenza seasons, 2010-2016.

M. Russell, F. Dawood, M. Katz, 2019, The Journal of infectious diseases.

Association of influenza vaccination during pregnancy with birth outcomes in Nicaragua

J. Bresee, M. Thompson, S. Olsen, 2017, Vaccine.

Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons.

Ivo M Foppa, A. Monto, B. Flannery, 2015, Vaccine.

Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

A. Monto, C. Rinaldo, E. Belongia, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influenza Vaccine Effectiveness in Preventing Influenza Illness Among Children During School-based Outbreaks in the 2014–2015 Season in Beijing, China

Ying Sun, P. Yang, Quanyi Wang, 2017, The Pediatric infectious disease journal.

Detection of Influenza Virus Infection Using Two PCR Methods

G. Balasubramani, C. Rinaldo, M. Nowalk, 2014, Advances in virology.

Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012.

Lauren E. W. Olsho, A. Randolph, N. Bhat, 2014, The Journal of infectious diseases.

Knowledge, attitudes and beliefs related to seasonal influenza vaccine among pregnant women in Thailand.

K. Lindblade, F. Dawood, M. Thompson, 2016, Vaccine.

Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

Andrew L. Phillips, Lauren E. W. Olsho, Krystal S. Jovel, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

William F. Fadel, S. E. Reese, M. Stockwell, 2022, MMWR. Morbidity and mortality weekly report.

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

Andrew L. Phillips, Lauren E. W. Olsho, K. Hegmann, 2021, MMWR. Morbidity and mortality weekly report.

Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013

S. Wisniewski, A. Monto, N. Cox, 2013, MMWR. Morbidity and mortality weekly report.

Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults — VISION Network, 10 States, December 2021–March 2022

William F. Fadel, C. Mcevoy, M. Stockwell, 2022, MMWR. Morbidity and mortality weekly report.

Immune-mediated attenuation of influenza illness after infection: opportunities and challenges.

A. Monto, M. Thompson, A. Fry, 2021, The Lancet. Microbe.

Influenza vaccine effectiveness in the community and the household.

B. Cowling, A. Monto, D. Shay, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence rates of influenza illness during pregnancy in Suzhou, China, 2015–2018

A. Iuliano, M. Thompson, Yan Wang, 2021, Influenza and other respiratory viruses.

Cohort profile: China respiratory illness surveillance among pregnant women (CRISP), 2015–2018

M. Thompson, Yan Wang, Liling Chen, 2018, BMJ Open.

Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research.

M. Thompson, A. Fry, S. Spencer, 2021, Vaccine.

Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.

Namrata Prasad, Nevil Pierse, Colin McArthur, 2018, Vaccine.

Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons.

S. Kurosky, D. Shay, A. Naleway, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Estimates of deaths associated with seasonal influenza --- United States, 1976-2007.

Erin Burns, Hong Zhou, Joseph S. Bresee, 2010, MMWR. Morbidity and mortality weekly report.

Prevention and Attenuation of COVID-19 by BNT162b2 and mRNA-1273 Vaccines

Andrew L. Phillips, Lauren E. W. Olsho, K. Hegmann, 2021, medRxiv.

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

William F. Fadel, S. Schrag, K. Natarajan, 2021, The New England journal of medicine.

Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains.

A. Monto, E. Belongia, J. Treanor, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel.

L. Grohskopf, D. Shay, Hong Zhou, 2012, Vaccine.

Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021

William F. Fadel, Sarah E. Reese, C. Mcevoy, 2021, MMWR. Morbidity and mortality weekly report.

Priming with MF59 adjuvanted versus nonadjuvanted seasonal influenza vaccines in children - A systematic review and a meta-analysis.

Manish M Patel, E. Azziz-Baumgartner, M. Thompson, 2019, Vaccine.

Respiratory syncytial virus hospitalisations among young children: a data linkage study

Q. S. Huang, C. Grant, M. Thompson, 2019, Epidemiology and Infection.

Intent to obtain pediatric influenza vaccine among mothers in four middle income countries.

L. Gresh, G. Kuan, A. Gordon, 2020, Vaccine.

Influenza and respiratory syncytial virus in infants study (IRIS) of hospitalized and non-ill infants aged <1 year in four countries: study design and methods

M. Lucero, L. Gresh, G. Kuan, 2017, BMC Infectious Diseases.

Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011–2012 and 2012–2013: The Importance of Two Priming Doses

A. Monto, B. Flannery, E. Belongia, 2016, The Pediatric infectious disease journal.

Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014.

H. Kelly, Q. S. Huang, M. Baker, 2016, Vaccine.

Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, BMJ.

Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status — Oregon and Washington, July 4–September 25, 2021

E. Azziz-Baumgartner, A. Naleway, M. Thompson, 2021, MMWR. Morbidity and mortality weekly report.

Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—Nine States, January–September 2021

S. E. Reese, C. Mcevoy, S. Schrag, 2021, American Journal of Transplantation.

Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.

S. E. Reese, M. Stockwell, R. Link-Gelles, 2023, Pediatrics.

SARS-CoV-2 infection history and antibody response to three COVID-19 mRNA vaccine doses.

Lauren E. W. Olsho, A. Fowlkes, K. Ellingson, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Protection of 2 and 3 mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized with COVID-19 - VISION Network, August 2021 - March 2022.

S. E. Reese, C. Mcevoy, P. Embí, 2022, The Journal of infectious diseases.

Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type

Richard K. Zimmerman, Alicia M. Fry, Michael L. Jackson, 2014, The Journal of infectious diseases.

Incidence and viral aetiologies of acute respiratory illnesses (ARIs) in the United States: a population-based study

P. Szilagyi, J. Treanor, D. Shay, 2016, Epidemiology and Infection.

Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility.

A. Monto, J. Petrie, S. Ohmit, 2015, The Journal of infectious diseases.

Factors associated with influenza vaccine receipt in community dwelling adults and their children.

A. Monto, A. Aiello, J. Petrie, 2014, Vaccine.

Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season.

Qingxia Chen, Yuwei Zhu, M. Thompson, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness — United States, February 2013

S. Wisniewski, A. Monto, N. Cox, 2013, MMWR. Morbidity and mortality weekly report.

Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults.

C. Reed, L. Finelli, M. Thompson, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of alternative full and brief versions of functional status scales among older adults in China

B. Cowling, V. Fang, A. Iuliano, 2020, PloS one.

Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial.

J. Peiris, B. Cowling, D. Skowronski, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons

T. Friedrich, E. Belongia, J. Meece, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effectiveness of Nonadjuvanted Monovalent Influenza A(H1N1)pdm09 Vaccines for Preventing Reverse Transcription Polymerase Chain Reaction–Confirmed Pandemic Influenza Hospitalizations: Case-Control Study of Children and Adults at 10 US Influenza Surveillance Network Sites

W. Schaffner, R. Lynfield, J. Meek, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol

D. Greenberg, T. Hertz, A. Monto, 2018, BMC Infectious Diseases.

Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized, Open-Label Trial

F. Dawood, W. Cao, B. Flannery, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

School‐Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program

M. Meltzer, D. Shay, D. Mills, 2017, Health services research.

A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates.

R. Davis, C. Hansen, M. Raebel, 2012, The Journal of infectious diseases.

Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016‐2018

F. Dawood, E. Ticona, M. Katz, 2020, Influenza and other respiratory viruses.

Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort Study (Preprint)

K. Hegmann, A. Fowlkes, A. Caban-Martinez, 2021 .

Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort Study

K. Hegmann, A. Fowlkes, A. Caban-Martinez, 2021, JMIR research protocols.

Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults

B. Cowling, V. Fang, Ranawaka A.P.M Perera, 2021, npj Vaccines.

Influenza-Associated Outcomes Among Pregnant, Postpartum, and Nonpregnant Women of Reproductive Age.

Q. S. Huang, M. Baker, M. Thompson, 2019, The Journal of infectious diseases.

Risk Factors and Attack Rates of Seasonal Influenza Infection: Results of the Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) Seroepidemiologic Cohort Study

R. Webby, Q. S. Huang, P. Thomas, 2018, The Journal of infectious diseases.

Results of a pilot study using self-collected mid-turbinate nasal swabs for detection of influenza virus infection among pregnant women

D. David, J. Meece, A. Naleway, 2015, Influenza and other respiratory viruses.

Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates.

H. Kelly, Q. S. Huang, V. Mishin, 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Influenza vaccination in tropical and subtropical areas.

B. Cowling, M. Thompson, Cuiling Xu, 2017, The Lancet Respiratory Medicine.

COVID-19 Infection, Reinfection, and Vaccine Effectiveness in a Prospective Cohort of Arizona Frontline/Essential Workers: The AZ HEROES Research Protocol.

Joel Parker, B. Cowling, K. Ellingson, 2021, JMIR research protocols.

COVID-19 Vaccination Perspectives and Illnesses Among Law Enforcement Officers, Firefighters, and Other First Responders in the US, January to September 2021

Lauren E. W. Olsho, A. Caban-Martinez, J. Burgess, 2022, JAMA network open.

High Burden of COVID-19 among Unvaccinated Law Enforcement Officers and Firefighters

Lauren E. W. Olsho, K. Hegmann, A. Fowlkes, 2021, medRxiv.

Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection

Lauren E. W. Olsho, A. Fowlkes, A. Caban-Martinez, 2021, medRxiv.

Reply to Skowronski, De Serres and Orenstein.

M. Katz, J. Kwong, A. Naleway, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Implementing hospital-based surveillance for severe acute respiratory infections caused by influenza and other respiratory pathogens in New Zealand.

R. Webby, Q. S. Huang, P. Thomas, 2014, Western Pacific surveillance and response journal : WPSAR.

Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019.

A. Monto, F. Dawood, R. Balicer, 2021, Vaccine.

Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China.

B. Cowling, M. Thompson, Cuiling Xu, 2018, Vaccine.

Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014.

H. Kelly, Q. S. Huang, M. Thompson, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Hemagglutinin and Neuraminidase Antibodies Are Induced in an Age- and Subtype-Dependent Manner after Influenza Virus Infection

R. Webby, Q. S. Huang, M. Thompson, 2020, Journal of Virology.

Incidence of SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential Workers During a Prevaccination COVID-19 Surge in Arizona

Joel Parker, K. Ellingson, J. Burgess, 2021, JAMA health forum.

Influenza and other respiratory virus infections in outpatients with medically attended acute respiratory infection during the 2011-12 influenza season

C. Rinaldo, M. Nowalk, R. Zimmerman, 2014, Influenza and other respiratory viruses.

Influenza Transmission in a Cohort of Households with Children: 2010-2011

B. Cowling, A. Monto, J. Petrie, 2013, PloS one.

How repeated influenza vaccination effects might apply to COVID-19 vaccines

B. Cowling, M. Thompson, 2022, The Lancet Respiratory Medicine.

Reduced serologic sensitivity to influenza A virus illness among inactivated influenza vaccinees.

A. Naleway, Sarah Ball, M. Gaglani, 2016, Vaccine.